DID MICHAEL DAVID MAINWALD CAUSE YOU INVESTMENT LOSSES?
Michael Mainwald Of Lek Securities Has A Customer Complaint For Alleged Broker Misconduct
Who is Michael Mainwald of Lek Securities?
Michael Mainwald (CRD #2766998) who is currently registered with Lek Securities and located in New York, New York is a subject of one of our many securities industry sales practice abuse investigations.
Michael Mainwald Customer Complaint
Michael Mainwald has been the subject of at least one customer complaint that we know about, which was filed in the last year to recover investment losses. The allegations made in the FINRA reported customer complaint for investment losses were violations of several FINRA rules by the firm including Rule 2010, 5310, 2150, 3110. The customer complaint filed against Michael Mainwald’s current employer Lek Securities for investment losses caused by the alleged misconduct is pending as of the date of this report.
Michael Mainwald Red Flags & Your Rights As An Investor
Of course, Michael Mainwald did not admit to any of the allegations. But regardless of whether an arbitration award was entered, a settlement occurred, or the customer complaint is still pending, the allegations made by customers are red flags which should put all current and former customers of Michael Mainwald at Lek Securities on alert to review carefully the activity and performance of their accounts and question whether Michael Mainwald has engaged in any stockbroker misconduct that may have caused them investment losses. The large number of customer complaints at Lek Securities also raises questions about the brokerage firm’s supervisory practices. If these red flags raise questions, call us and we will inform you of your rights as an investor.
File A Claim To Recover Your Investment Losses At Lek Securities Due To Michael Mainwald
If you have questions about Lek Securities and/or Michael Mainwald and the management or performance of your accounts, please contact Attorney Pearce for a free initial consultation via email or Toll Free at 1-800-732-2889.